[Attempted athero-regression].

[Correlations between risk factors and atherosclerotic disease of the carotid arteries. Investigation with the Duplex scanner]. Minerva Cardioangiol (1986) 0.75

[Secondary prevention of coronary disease with platelet aggregation inhibiting drugs. Preliminary report]. Minerva Cardioangiol (1979) 0.75

[Current dietetic and pharmacological treatment of hyperlipoproteinemia]. Minerva Med (1975) 0.75

[Isiopathic diffuse calcinosis and arteriosclerosis. Considerations on a case of idiopathic diffuse calcinosis with arteriosclerosis obliterans of the lower limbs]. Minerva Cardioangiol (1976) 0.75

[Dietetic treatment of hypercholesteremia. Academic or pragmatic approach]. Minerva Cardioangiol (1979) 0.75

[Giant-cell temporal arteritis with the aortic arch syndrome. Description of a clinical case]. Minerva Med (1968) 0.75

Multicentre study of soybean protein diet for outpatient hyper-cholesterolaemic patients. Lancet (1980) 0.75

[On a case of recurrent ventricular fibrillation with favorable course]. Minerva Cardioangiol (1967) 0.75

[Effects of medical therapy on long-term survival in ischemic heart disease]. Minerva Cardioangiol (1984) 0.75

[Surgical revascularization of the myocardium]. Minerva Cardioangiol (1981) 0.75

[Diagnostic problems in the aortic arch syndrome. Clinical contribution on 5 cases]. Minerva Med (1968) 0.75

[Platelet anti-aggregant and anticoagulant therapy in the secondary prevention of coronary disease. Preliminary note]. Boll Soc Ital Cardiol (1977) 0.75

[Correction of thrombophilia]. Minerva Cardioangiol (1981) 0.75

[The action of 1,4-dicaffeylquinic acid on the lipid fractions of the blood in atherosclerosis]. Minerva Med (1969) 0.75

[Anti-hyperlipemic therapy in the secondary prevention of coronary heart disease. Long-term study]. Boll Soc Ital Cardiol (1974) 0.75

[So-called idiopathic auricular fibrillation. Coronaro-cineventriculographic study]. Minerva Cardioangiol (1976) 0.75

[Comparison between Doppler CW and Duplex-Scanning in the assessment of silent peripheral vascular lesions in a population of ischemic heart disease patients]. Minerva Cardioangiol (1989) 0.75

[Coronary angiography in primary myocardial diseases]. Minerva Cardioangiol (1975) 0.75

[The lipid hypothesis in the etiopathogenesis of ischemic heart disease: confirmations and doubts resulting from primary prevention trials]. Minerva Cardioangiol (1989) 0.75

[Effects of simvastatin on plasma levels of lipids, lipoproteins and apolipoproteins in primary hypercholesterolemia]. Minerva Cardioangiol (1989) 0.75

[Prolonged treatment of coronary insufficiency with heparin in clarifying doses and essential phospholipids]. Therapeutique (1969) 0.75

[Correction of the primary and secondary risk factors in coronary dis]. Minerva Cardioangiol (1981) 0.75

[Secondary prevention of ischemic cardiopathy]. Cardiologia (1995) 0.75

[Changes of blood lipid fractions produced by phosphatidyl choline in patients with atherosclerosis]. Minerva Med (1969) 0.75

[Correlations between risk factors and morphology of carotid atherosclerotic lesions studied with the Duplex-Scanner]. Minerva Cardioangiol (1986) 0.75

[Familial aggregation of ischemic cardiopathy]. Minerva Cardioangiol (1986) 0.75

[Natural history of ischemic cardiopathy]. Minerva Cardioangiol (1981) 0.75

[Surgical cardiac risk in patients with heart diseases. II. Perioperative treatment]. Minerva Cardioangiol (1989) 0.75

[Surgical cardiac risk in patients with heart diseases. I. Evaluation of the risk]. Minerva Cardioangiol (1989) 0.75

[Effect of various risk factors on long-term survival in ischemic heart disease]. Minerva Cardioangiol (1984) 0.75

Toxic polyneuritis and toxic hepatitis related to long-term perhexiline maleate therapy. Am Heart J (1980) 0.75

[Hypertension and arteriosclerosis. Correlations and prospects of preventive therapy]. Minerva Cardioangiol (1976) 0.75